Respiratory conditions are abundant, on the rise and have a major impact on the quality of life of patients
More than 1 in 4 people suffer from chronic illnesses. A staggering 75% of healthcare spending in Europe is linked to managing chronic conditions. Integrated care implies coordination and strong collaboration among healthcare actors, from primary care to rehabilitation, with the patients’ needs placed at the center.
The goal is to provide higher quality care, improved health outcomes, and better patient experience within the care journey.
Integrated Care for a better Health
Policymakers and stakeholders are well aware of the importance of integrated care. In 2015, the ministers responsible for public health at regional and federal level in Belgium adopted a common plan to tackle chronic disease, entitled “Integrated Care for a better Health”. A series of pilot projects have been set up in the meantime, and the new government agreement refers explicitly to integrated care.
Through a series of targeted roundtables, the workstream aims to come to a set of recommendations that will be handed over to the medical societies and the world of politics for further discussion, refinement, dissemination and ultimately implementation to the benefit of Belgian patients.
Today, the workstream focuses on 3 specific lung diseases: asthma, COPD and diseases triggered by an underlying type-2 inflammation.
Frank Pieters, CEO P&L Projects, chairman of the board at Softhale NV, head of strategy and business development at Aquilon.
Point of View 'Patients suffer from constructions in and near hospitals'
Point of View 'Modern hospitals should focus more on air purification.'
Introduction note type2
Proceedings Type 2 Inflammation Roundtable 2
Proceedings Type 2 Inflammation
Belgium In Urgent Need Of A National Asthma Plan
Pulmonary Innovation Forum
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi, Empowering Life.
The VRGT is an organisation passionate about the human lung and working hard to defeat lung diseases. Our mission? To be the centre of expertise regarding TBC, but also to be a key player in respiratory health with a focus on encouraging and helping people to quit smoking.
The Belgian Respiratory Society (BeRS) is a scientific association of doctors, nurses, physiotherapists and scientific researchers with an interest in the field of lung diseases. The primary objectives of the BeRS are to promote respiratory health and to combat respiratory diseases in Belgium.